This retrospective study was conducted to evaluate the safety and complications profile of general anaesthesia (GA) compared with that of regional anaesthesia (RA) for BM harvesting (BMH). The study included 281 donations carried out between 1992 and 1999. Of these, 204 (73%) were allogeneic donations, and GA was carried out in 69% (140 of 204) and RA in 31% (64 of 204) of cases. The other 77 donations were autologous (27%), using GA in 87% (67 of 77) and RA in 13% (10 of 77) of cases. No life-threatening complications occurred, but there were minor intra-and postoperative events during 26 (9%) and after 58 (21%) donations. Postoperative nausea and vomiting was reported in 40 (14%) cases and post-spinal headache after five out of 58 (8.6%) donations in which spinal anaesthesia was carried out. The incidence of intraand postoperative events did not differ significantly between the GA and RA groups. However, the incidence of postoperative events was higher in the allogeneic group compared with that in the autologous group (25 vs 10%, Po0.01) and in female donors compared with male donors (29 vs 14%, P ¼ 0.002). In conclusion, both GA and RA are comparable with regard to BMH. Nevertheless, non-severe intra-and postoperative events were frequent.
Introduction
Several stem-cell sources such as mobilised PBSCs, BM or umbilical cord blood are suitable for haematopoietic SCT in clinical practice. BM harvesting (BMH) is a wellestablished, effective and safe method for the collection of haematopoietic stem cells. [1] [2] [3] Although during the last decade PBSCs have almost replaced BM as a stem-cell source in autologous transplantations, and PBSCs are used in the majority of cases in allogeneic settings, BM still remains a valuable stem-cell source in some cases. BMH is typically performed from the posterior iliac crest, the richest site for BM harvest, under general or regional anaesthesia (GA or RA). There is no 'anaesthesia of choice' for this procedure. Although both methods of anaesthesia are generally considered safe and are commonly used, there are only a few reports in which their safety and efficacy among stem-cell donors have been compared. [4] [5] [6] The choice of the type of anaesthesia most often depends on local routines as well as on donor and anaesthetist preferences.
The purpose of our study was to evaluate retrospectively the impact of GA and RA in connection with 281 allogeneic and autologous donations carried out at Karolinska University Hospital Huddinge.
Materials and methods

Donors
We reviewed 281 hospital records of adult BM donors, aged 15-64 years, who underwent BMH at Karolinska University Hospital Huddinge between January 1992 and December 1999. Allogeneic marrow was donated on 204 occasions (73%) and autologous marrow on 77 occasions (27%). Of the 204 allogeneic donations, 113 (55.4%) were from related donors and 91 (44.6%) were from unrelated donors. All unrelated donors were from the Swedish Donor Registry (Tobias registret). In eight donors (four autologous and four allogeneic) from whom two aspirations were obtained at different times, each harvest was considered separately. Donor characteristics are presented in Table 1 .
Data on the following variables were recorded: age, gender, function group according to the American Society of Anesthesiologists (ASA) classification, type of donation (autologous and allogeneic), type of anaesthesia (GA, RA-spinal or epidural), drugs given as premedication, intra-operative complications, peri-operative i.v. fluid requirements (crystalloids, colloids, erythrocyte transfusions (autologous or allogeneic) or platelet transfusion), volume of BM aspirated, postoperative analgesia (opioids, non-opioid analgesics or epidural anaesthetics), postoperative complications (headache, postoperative nausea and vomiting (PONV) and other), duration of preparation for General vs regional anaesthesia for BM harvesting M Machaczka et al anaesthesia, collection time (the time interval between the start and the end of marrow collection), duration of the discharge period, anaesthesia time (the interval between the time of administration of anaesthesia and the time of discharge from the operating room) and duration of stay in the post-anaesthesia care unit. The ASA classification that we used is the system for ranking the level of a patient's physical health, dividing patients into five function groups (classes): I-healthy subject; II-a patient with a mild disease causing no functional limitation; III-a patient with a serious disease, which may limit normal activity but does not cause incapacitation; IV-a patient with a life-threatening and incapacitating disease; V-a declining patient who is not expected to live beyond a day, regardless of the medical attention.
In our study, five allogeneic donors (2.4% of all allogeneic donations; 5 of 204) were considered as increased-risk donors from an anaesthesiological point of view. They were as follows: a 20-year-old pregnant female; a 32-year-old female with hypothyroidism; a 52-year-old male with a history of severe hypertension; a 36-year-old male with sleep apnoea syndrome; and a 51-year-old male donor who proved to be HCV positive, but as conditioning of the recipient had already begun when HCV status was reported, BMH was performed.
The pregnant female in our study was a related donor and she insisted on donating marrow in spite of her pregnancy to save the life of her brother. The HCV-positive donor with mild but active liver disease had increased risk for liver damage during anaesthesia compared with healthy allogeneic donors. This risk is related to the direct hepatotoxic effect of anaesthetic agents as well as on haemodynamic alterations taking place in a more vulnerable liver parenchyma. Besides, the patient with a past medical history of severe treatment-resistant hypertension, requiring several antihypertensive drugs with different mechanisms of action, had increased risk of haemodynamic complications during anaesthesia, even though blood pressure was corrected before administration of anaesthesia. ASA function group II was also assigned to otherwise healthy but smoking donors.
The ASA function group III should be assigned to a patient (donor) with a serious disease (that is, systemic, such as leukaemia or lymphoma), which may limit normal activity but does not affect the patient's vital signs. Autologous donors were patients with severe medical conditions, often heavily pre-treated, and these were the reasons that some of them were classified as function group III (18.4%). Nevertheless, a majority of autologous donors were assessed as function group II (63.2%).
BM aspiration procedure BM was collected from multiple entry sites on the posterior iliac crests of the donor in the prone position. Multiple samples of 2-5 ml of marrow were taken in syringes that had been rinsed with heparin-containing solution. The aim of marrow donation was to collect 3 Â 10 8 TNC (total nucleated-cell number)/kg of the recipient bodyweight. After collecting 450 ml of donor's BM, the analysis of TNC was performed intra-operatively and the estimated marrow volume was calculated. After completing BMH, the total number of TNC was calculated again on the total volume of harvested marrow. In cases where a large amount of BM was required, additional marrow was obtained from the anterior crests. All donors routinely received antibacterial prophylaxis, usually with dicloxacillin or cloxacillin, and more rarely with vancomycin or clindamycin.
Anaesthesia procedure
The physician's choice was the most important factor for the choice of anaesthesia type between 1992 and 1995. GA was the routine anaesthesia technique used for BMH, unless RA was actively chosen by the donor after consultation with the anaesthesiologist, or it was otherwise indicated. Between 1996 and 1999, the donor's choice was the most important factor while selecting the method of anaesthesia. However, there were no significant differences in the ratio of GA and RA during these two time periods. There were 160 marrow donations from 1992 to 1995. Of these, 76.9% (123 of 160) were performed using GA and 23.1% (37 of 160) using RA. Between 1996 and 1999, 121 BM donations were carried out. Of these, 69.4% (84 of 121) of donations were carried out using GA and 30.6% (37 of 121) using RA.
All patients were monitored with pulseoxymetry, and the recorded values were normal in all patients. Patients undergoing GA were put on a ventilator (simplified respirator) and their ET CO2 was followed up and kept within normal limits.
Premedication
For premedication, a combination of morphine and scopolamine was mostly used for the first 3 years of the study period. For the remaining years, the routine drugs used were diazepam or midazolam.
General anaesthesia
General anaesthesia was administered with thiopental. After endotracheal intubation with a flexible spiral tube and mechanical ventilation, anaesthesia was maintained with isoflurane in oxygen/nitrous oxide, with the supplementary use of small doses of midazolam and fentanyl. Suxamethonium was used for muscle relaxation until endotracheal intubation, and afterwards pancuronium or atracurium was administered.
Regional anaesthesia
Regional anaesthesia was administered in patients in the sitting position; the patients were then immediately made to lie down in the supine position and after 5 min were turned over to the prone position. For spinal anaesthesia (subarachnoidal block), a Sprotte needle (24G) was used, with bupivacain. In many patients, midazolam was used for intra-operative sedation. The initial level of anaesthesia block was Th 6-8. With this level of blockage, occurrences of complications from the autonomic nervous system are extremely uncommon. For lumbar epidural anaesthesia, a Touhy needle (18G) was used, with bupivacain plus epinephrine, or mepivacain plus epinephrine. A continuous technique with a catheter was used to facilitate postoperative epidural analgesia. In many patients, midazolam was used for intra-operative sedation.
The dose of midazolam was 1 mg i.v., and the aim was to diminish anxiety and not to induce sleep. When indications occurred, the initial dose of midazolam could be repeated (once or twice).
The reasons for the choice of epidural anaesthesia in 11 patients rather than spinal anaesthesia were the estimated time of BMH as well as the personal choice of the anaesthesiologist. Epidural anaesthesia was favoured in cases of longer estimated time of marrow collection.
Fluid and blood supplementation There were several practices regarding fluid and blood supplementation during the study period, and often decisions regarding infusion of fluids were largely taken by the physician-in-charge. All donors were given crystalloid solutions to maintain blood pressure within the normal range (Ringer's acetate solution or glucose solution was used). Donors in the RA group routinely received an additional amount of 500 ml of crystalloid solution in combination with ephedrine as prophylaxis against sympathicolysis. The given dose of ephedrine was 5 mg i.v., and the dose could be repeated once. Transfusions of preoperatively removed autologous whole blood, or erythrocytes separated from the BM and colloid solution in the form of albumin (35-50 mg/ml) were used for compensating the volume of BM aspirated.
When possible, autologous blood was collected before BM donation. However, some allogeneic donors were not a subject of autologous blood collection because of the presumed low volume of harvested BM (for example, adults donating BM for children), the lack of time to prepare collection (for example, donors for non-transfused SAA patients) or if the donor was not available in good time before BMH. Blood of the autologous donors was collected if they were transfusion independent and had a stable Hb level. At the beginning of this study, a reasonable number of autologous BMH was from patients suffering from acute leukaemia, and it was often difficult to collect autologous blood for this group. The general policy of autologous RBCs support was to transfuse the collected blood to the donor regardless of anaesthesia type.
Postoperative management
After donation, the donors were transferred to the postanaesthesia care unit for a few hours and thereafter to the haematological ward, where they remained for at least 24 h for observation. All donors experienced a degree of pain. The use, choice and route of certain analgesics (opioid, non-opioid analgesic agents, orally, subcutaneously, intramuscularly, intravenously or epidurally) depended on the physician-in-charge. In the last few years, the use of a visual analogue scale has been introduced, and the donors were asked to indicate their postoperative pain level on a visual scale numbered from 0 to 10. Nevertheless, the use of specific analgesic agents still depended on the physician-incharge. All donors were seen 3 weeks after the donation for a follow-up examination.
Analysis of data
Data are summarised as median and range. To determine statistical significance, Student's t-test for independent variables was used to compare quantitative parameters, and Fisher's exact test or Chi-square analysis was performed, as appropriate, to compare qualitative parameters. Differences were considered significant at Po0.05.
Results
General donor characteristics
Data were obtained on 273 adult BM donors (median age 40, range 15-64 years) from a total of 281 donations. The female-to-male ratio was 4:5. General characteristics of the donors and donations are shown in Table 1 . Autologous marrow was donated on 77 occasions (27%) (median age 49, range 17-64 years) (autologous group). In this group, GA was used in 67 (87%) and RA in 10 (13%) donations. Allogeneic marrow was donated on 204 occasions (73%) (median age 37, range 15-60 years) (allogeneic group). GA was used in 140 (69%) cases and RA in 64 (31%) cases.
In general, symptoms that occur during and after BMH because of anaemia are secondary to hypoxia and hypovolaemia. Both of them were carefully followed up and corrected in all patients by experienced anaesthesiologists. Anaemia-related hypoxia was corrected by oxygen supply, by routine transfusion of autologous blood (81.1% of all donations, 228 of 281) started after completion of BMH (without earlier control of RBC or Hb) as well as, if indicated, by allogeneic RBCs transfusions in few cases (5.3%, 15 of 281). In our institution, control of complete blood count after BMH was not carried out on a routine basis in healthy donors after allogeneic BMH.
Only 12% (15 of 125) of female donations and 19.2% (30 of 156) of male donations required a BM volume of 1300 ml or higher. Only 4% (5 of 125) of female donations and 10.9% (17 of 156) of male donations required a BM volume of 1500 ml or higher. Moreover, donors of higher marrow volumes (1300 ml or more, as well as 1500 ml or more) did not experience more intra-operative and postoperative events as compared with donors of lower marrow volumes (o1300 ml).
Complications Intra-operative anaesthesia-related events (Table 2) were reported in 26 cases (9.3% of 279 donations), and, in 58 cases (20.7% of 280 donations), one or more minor postoperative events were reported (Table 3) . Headache occurred in five of 58 donations in which spinal anaesthesia was carried out (8.6%). No additional adverse sequelae followed the events shown in Tables 2 and 3 .
Thrombophlebitis at the site of venous catheter insertion (Table 3 ) occurred in eight donors of allogeneic marrow (3.9% of 207 donors). Their median age was 33 (range 25-48), the female-to-male ratio was 5:3 and they were ASA function group-I donors. Seven of eight donors who General vs regional anaesthesia for BM harvesting M Machaczka et al experienced thrombophlebitis underwent GA. All eight events were seen during a 12-month period in which a total of 26 BMH procedures were performed (the incidence of thrombophlebitis in that period was 31%). All eight donors had received antibiotic prophylaxis (six with dicloxacilline and two with cloxacillin). Increased requirements for postoperative analgesia and a higher incidence of PONV were significantly different between allogeneic donors with and without thrombophlebitis (88 vs 47%, P ¼ 0.002 and 75 vs 14%, P ¼ 0.0003, respectively). Urinary retention was seen in six cases of allogeneic donation (2.1% of 280 donations). Their median age was 42 (range 21-55), the female-to-male ratio was 1:2 and they were all ASA function group-I donors. Five of them underwent GA and one underwent spinal anaesthesia. The median volume of crystalloids infused was 2750 ml (range 2000-3000 ml), four of six donors required colloid infusions (median volume 325 ml, range 0-500 ml) and five of six donors underwent autologous blood transfusion. Donors with urinary retention received more crystalloids than did those without (2750 ml; range 2000-3000 ml vs 1600 ml; range 400-4000 ml, P ¼ 0.001). All events were treated successfully with single-event bladder catheterisation.
General vs regional anaesthesia
The incidence of intra-and postoperative complications did not differ significantly between GA and RA donors; nor did postoperative analgesia requirements ( Table 4 ). The frequency of intra-and postoperative complications did not differ significantly when GA and RA were compared in the groups of allogeneic donors, autologous donors, female donors, male donors, donors with o1000 ml of BM aspirated and donors with 1000 ml or more of BM aspirated. The only exception to this was with regard to PONV which, although not significantly, was more frequent in donors receiving GA than in those receiving RA ( Table 4 ). The incidence of PONV, however, was significantly more common after GA than after RA in the group of donors with o1000 ml of BM aspirated (15 vs 3%, Po0.05) and in the allogeneic group (20 vs 8%, P ¼ 0.02). The volumes of crystalloid infusions were significantly higher in donations with RA compared with those with GA (Table 4) , and the requirement for autologous blood in the autologous group was more frequent in cases of GA than in those of RA (73 vs 40%, Po0.007).
Younger donors (o41 years, median age in GA donations) undergoing GA required postoperative analgesia more frequently and suffered from more postoperative events than did older donors undergoing GA (54 vs 35%, Po0.01 and 29 vs 16%, P ¼ 0.02, respectively). The incidence of intra-operative events and postoperative analgesia requirements was greater in younger (o37 years, median age in RA donations) than in older donors undergoing RA (23 vs 3%, P ¼ 0.01 and 49 vs 26%, P ¼ 0.04, respectively).
General and regional anaesthesia were not found to differ significantly with regard to the time required for harvesting similar amounts of BM in all donors, in the allogeneic group or in the autologous group.
Autologous vs allogeneic donation
General anaesthesia was used more frequently in the autologous group than in the allogeneic group (Table 1) . The needs for allogeneic blood and for colloid infusions were significantly greater for autologous than for allogeneic donors. Postoperative events and postoperative analgesia requirements were more frequent in the allogeneic than in the autologous group (Table 1) .
In the allogeneic group, PONV was more frequent after GA donations compared with that after RA donations (20 vs 8%, P ¼ 0.012). The incidence of PONV was found to be significantly higher in younger (o36 years, median age in the allogeneic group) than in older allogeneic donors (23 vs 10%, P ¼ 0.02). The consumption of opioid analgesics was greater in the GA group compared with that in the RA Six patients presented with two events at the same time: three with events 1+2 and three with events 2+3. One patient presented three events (1+2+3). a n ¼ 179 donations.
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Female vs male donors
Female donors suffered more from postoperative events and required significantly more postoperative analgesia compared with male donors (29 vs 14%, P ¼ 0.002 and 50 vs 35%, P ¼ 0.01, respectively). These results were confirmed in the allogeneic group (35 vs 17%, P ¼ 0.003 and 59 vs 41%, P ¼ 0.01, respectively) but not in the autologous group. PONV was reported by 24% of female allogeneic donors and by only 11% of male allogeneic donors (Po0.02). The use of opioid analgesics was greater in women than in men with regard to all donations as well as in the allogeneic group (35 vs 21%, P ¼ 0.01 and 41 vs 24%, P ¼ 0.01, respectively). Female GA donors reported more postoperative events (30 vs 14%, Po0.01), including headache and PONV, than did male GA donors.
Females who donated higher volumes of BM (1300 ml or more) did not experience more postoperative events or side effects compared with females donating o1300 ml of marrow or with males in general, or with males donating more than 1300 ml of marrow.
Discussion
It is believed that RA may offer some benefits for the patient, including fewer major and minor complications, when compared with GA. These benefits include (1) reduced blood loss intra-operatively because of decreasing peripheral venous pressure; (2) patients' ability to change the position of arms, legs and chest, as needed to avoid nerve injury, brachial plexus palsy or pressure necrosis in either the face or chest wall; (3) reduced incidence of nausea and vomiting postoperatively; (4) better postoperative analgesia; (5) decreased stress response; (6) preservation of immune response; (7) shorter hospitalisation time; as well as (8) cost reduction. 5, 6, 7, 8, [9] [10] [11] [12] [13] [14] These benefits of RA should counterbalance the risk of respiratory complications (including respiratory depression) in a sedated pronepositioned patient when compared with GA (with a secured airway). 14 Spinal and anorectal surgery are the procedures carried out in the same body position as that for BMH (the prone position). However, studies on the choice of anaesthesia for anorectal surgery include many less patients than those for spinal surgery. In a prospective study of 122 patients who underwent lumbar disk and laminectomy surgery, Jellish et al. 13 found RA superior to GA. For the RA group (61 patients), the authors reported shorter total anaesthesia and surgery time, lower incidence of increased blood pressure intra-operatively, less severe nausea and pain postoperatively, lower heart rates and mean arterial pressure postoperatively. This study, composed of a smaller number of patients, is the only completed and published prospective trial on the anaesthesia choice for spinal surgery. McLain et al.
14 in a more recent retrospective comparison of GA vs RA in 400 patients who underwent lumbar laminectomy found similar results. In the RA group (200 patients), the authors reported shorter anaesthesia and surgery time, less PONV, lower consumption of analgesics and a lower overall complication rate, including urinary retention.
Considering that only a few studies have involved investigations on the impact of anaesthesia technique on BM donors, it is hard to argue that potential problems of RA in a sedated prone-positioned patient might not arise, even though they have not been reported earlier. [4] [5] [6] 15 Currently, there is no consensus regarding the preferable anaesthesia method for BMH, and the choice between GA and RA is still controversial. Only a comparison of these two anaesthesia methods in a well-defined patient setting is sufficient to prove if there are indeed some advantages of one anaesthesia technique over the other. 8, [10] [11] [12] The specificity of allogeneic BMT is that the timing of BM donation is strictly linked to the issues related to the recipient (current treatment, disease stage, started conditioning and so on). It means that, even if BMH is an elective procedure for the donor, its timing is vital for the recipient. In very rare cases, if donation is a vital necessity for the recipient and delay in the planned marrow collection is not possible (that is, started conditioning), the collection is performed, unless there is a vital contraindication in the donor. However, especially as related donors are under a lot of familial pressure, a thorough predonation check-up is mandatory, and in high-risk donors, a physician not responsible for the recipient's transplantation has to ensure that the donor's interests are guaranteed. Moreover, if donor health is at risk, other therapeutic options for the patient have to be considered. Nevertheless, we would like to emphasise that none of the allogeneic donors in this study were classified as high-risk donors (ASA function group III or higher).
Earlier studies have shown a frequency of up to 0.3% for life-threatening complications such as cardiac arrest, ventricular tachycardia, cerebral infarction, bronchospasm and serious infections after BMH. [1] [2] [3] 16, 17 A somewhat higher frequency of 0.97% has been reported after BM aspiration for autologous transplantation. 18 Nevertheless, in our study, no life-threatening intra-or postoperative complications were observed, either among autologous or allogeneic donors. One possible factor influencing the generally low frequency of life-threatening complications associated with BMH is patient selection by a haematologist, choosing subjects of younger rather than of older age, combined with a lack of serious illness. Urwin et al. 12 performed a meta-analysis of 15 randomised trials involving a total of 2162 patients, comparing GA and RA for hip fracture surgery. In these elderly and non-preselected patients (mean age 74-86, depending on the study), there was a reduction of 1-month mortality and a tendency towards a lower incidence of myocardial infarction, confusion and postoperative hypoxia in those who underwent RA. Cerebrovascular accidents and intra-operative hypotension showed a trend towards a lower incidence in the GA group. However, it should be emphasised that Urwin's meta-analysis is related to surgery not performed in the prone-positioned patients, and the complications profile might be influenced by this fact rather than by BMH. Unfortunately, to the best of our knowledge, there are no similarly large studies comparing GA with RA in prone-positioned patients.
Minor intra-and postoperative events were relatively frequent in our study (9 and 21%, respectively) and as common for BMH as reported by others. 4 The incidence of intra-and postoperative events did not differ significantly between the GA and RA groups, with the single exception of PONV. The incidence of PONV was significantly greater after GA than after RA, particularly in the allogeneic group. Similar findings have been reported by others while comparing GA with RA for BMH, as well as for another surgical procedures. 6, 7, 11, 13, 14 In an earlier retrospective study of 162 BM donations (63 allogeneic and 99 autologous), Lavi et al. 4 found that patients who underwent GA required more RBC units than those undergoing RA. Our results do not confirm this finding. There were no significant differences in requirements with regard to blood transfusions or peri-operative colloids in the GA vs the RA group. A possible explanation for the greater demand for blood transfusions in the GA group in the study reported by Lavi et al. 4 could be a different distribution of patients, with relatively more autologous donors than in our study (57 vs 27%). Autologous donors of BM, according to our data, needed more autologous and allogeneic blood transfusions than did allogeneic donors, and more autologous blood when BMH was carried out under GA rather than under RA (73 vs 40%, respectively). This is in accordance with data obtained by Burmeister et al. 6 in a prospective study of 37 healthy allogeneic donors, in which no difference in blood requirements between the GA and RA groups was found.
Relief of postoperative pain is thought to be better after RA than after GA. 7, 10, 11 As a consequence, less postoperative analgesic medication is required after RA. This finding was confirmed with regard to BMH by Lavi et al. 4 in a retrospective study and by Burmeister et al. 6 in a prospective study. In our study, 44% of donors in the GA group and 37% of donors in the RA group required analgesia postoperatively, but this difference was not significant.
A shorter procedural time was reported by Knudsen et al. 5 for autologous BMH with spinal anaesthesia (10 patients) when compared with a historical control group of 51 patients who underwent BMH under GA. Our data with regard to 195 GA donations and 69 RA donations do not confirm this result. We found that the collection time was similar (GA 80 min vs RA 85 min) for both anaesthesia groups.
We do not have enough convincing data to believe that a higher incidence of postoperative events and side effects in female donors compared with male donors can be explained by a higher degree of anaemia in female donors.
Hypovolaemia and hypoxia were carefully followed up and corrected in all patients. Moreover, females who donated higher volumes of BM (1300 ml or more) did not experience more postoperative events or side effects compared with females donating o1300 ml of marrow or with males in general, or with males donating more than 1300 ml of marrow.
An interesting finding in our study was the occurrence of thrombophlebitis at the site of venipuncture as a postoperative event. It occurred only in allogeneic donors at a frequency of 3.9% (8 of 204), and all had received antibacterial prophylaxis. Autologous donors usually had central venous lines and no peripheral venous catheters were used. All events took place during a 12-month period and no case of thrombophlebitis was seen before or after that period. We evaluated possible factors, such as staff skills, venous catheters, materials and i.v. drugs used intraand postoperatively, but no specific cause was found. The only significant differences seen between allogeneic donors with and without thrombophlebitis were as follows: increased requirements for postoperative analgesia (88 vs 47%), especially non-opioid analgesia, and a higher incidence of PONV (75 vs 14%). Thrombophlebitis after venipuncture and subsequent drug administration is a relatively common complication, with a frequency of 2-87%. 19 It seems possible that vomiting, which was significantly more frequent in donors with vs those without thrombophlebitis, might have played a role as a consequence of the Valsalva reflex that accompanies retching/ nausea, 20 but it seems unlikely that this was the sole aetiological factor in all cases. Other factors, such as rate of injection, location and size of veins, arm immobilisation and blood pressure cuff placement on the same arm, have also been proposed to be important factors in the development of superficial thrombophlebitis after venipuncture. 19, 20 Urinary retention is a common postoperative problem and it is associated with risks of over-distension and permanent detrusor damage. 21, 22 Its incidence ranges from 7 to 52% depending on surgery type, anaesthesia method, analgesics and anticholinergics used, as well as the underlying medical conditions that may predispose patients to urinary retention. 22 We found urinary retention to occur at a frequency of 2.9% among allogeneic donors (6 of 204), which is less frequent than that in other surgical procedures 22 but more frequent than that earlier reported for allogeneic BMH. 6 Most of our patients with urinary retention were male (4 of 6), their median age was 42 and five patients underwent GA and one RA. They were found to have received significantly more crystalloids perioperatively, compared with the donors without urinary retention. An increased volume of fluids peri-operatively results in over-distension of the bladder and decreases its ability to contract. 21 BMH is still performed worldwide. At our institution, since the year 2000; B120 SCTs are performed annually, but only 1-3 BMHs per year. An uncomparable lower number of patients undergoing this procedure nowadays compared with the situation before the year 2000 is the major obstacle in prospectively validating old truths about anaesthesia choice for marrow harvesting. To our knowl-edge, this retrospective study represents the largest report so far in which the impact of general and regional anaesthesia in BMH has been evaluated. It shows that both GA and RA are comparable procedures with regard to BMH. We found no significant advantage of one technique over the other. A possible reason for this could be that the majority of adult donors are relatively young and healthy individuals and, as a consequence, not as vulnerable to the possible disadvantages of a particular anaesthetic technique. However, as known from other patient groups, one might expect some important differences in outcome depending on anaesthesia method. 8, [12] [13] [14] Available data suggest reduced mortality and morbidity among patients undergoing surgical procedures under RA. On the other hand, as a result of progress in SCT techniques and supportive care in recent years, there is a tendency to raise the age limit for BM donors. As a consequence, it could lead to a change in the complications profile. Our opinion is that the problem of anaesthesia choice for BMH remains unresolved. We hope that our data may serve as a basis and inspiration to design a prospective, probably multi-centre, randomised trial on the issue, as well as a background for comparison and discussion of complications profiles in studies focusing on donations of PBSCs.
